Small animal positron emission tomography in food sciences

被引:6
作者
Bergmann, R [1 ]
Pietzsch, J [1 ]
机构
[1] Res Ctr Rossendorf, Inst Bioorgan & Radiopharmaceut Chem, PET Ctr, D-01314 Dresden, Germany
关键词
positron emission tomography; food sciences; small animal PET scanners; PET tracer;
D O I
10.1007/s00726-005-0237-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Positron emission tomography (PET) is a 3-dimensional imaging technique that has undergone tremendous developments during the last decade. Non-invasive tracing of molecular pathways in vivo is the key capability of PET. It has become an important tool in the diagnosis of human diseases as well as in biomedical and pharmaceutical research. In contrast to other imaging modalities, radiotracer concentrations can be determined quantitatively. By application of appropriate tracer kinetic models, the rate constants of numerous different biological processes can be determined. Rapid progress in PET radiochemistry has significantly increased the number of biologically important molecules labelled with PET nuclides to target a broader range of physiologic, metabolic, and molecular pathways. Progress in PET physics and technology strongly contributed to better scanners and image processing. In this context, dedicated high resolution scanners for dynamic PET studies in small laboratory animals are now available. These developments represent the driving force for the expansion of PET methodology into new areas of life sciences including food sciences. Small animal PET has a high potential to depict physiologic processes like absorption, distribution, metabolism, elimination and interactions of biologically significant substances, including nutrients, 'nutriceuticals', functional food ingredients, and foodborne toxicants. Based on present data, potential applications of small animal PET in food sciences are discussed.
引用
收藏
页码:355 / 376
页数:22
相关论文
共 320 条
[1]   Positron emission tomography imaging of small animals in anticancer drug development [J].
Aboagye, Eric O. .
MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (01) :53-58
[2]   Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors [J].
Achilefu, S ;
Srinivasan, A ;
Schmidt, MA ;
Jimenez, HN ;
Bugaj, JE ;
Erion, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) :3403-3411
[3]  
Alauddin MM, 2004, J NUCL MED, V45, P2063
[4]  
Aloj L, 2004, J NUCL MED, V45, P485
[5]   Radiolabeling approaches for cholecystokinin B receptor imaging [J].
Aloj, L ;
Panico, MR ;
Caracó, C ;
Zannetti, A ;
Del Vecchio, S ;
Di Nuzzo, C ;
Arra, C ;
Morelli, G ;
Tesauro, D ;
De Luca, S ;
Pedone, C ;
Salvatore, M .
BIOPOLYMERS, 2002, 66 (06) :370-380
[6]   Radiometal labeled agents (non-technetium) for diagnostic imaging [J].
Anderson, CJ ;
Welch, MJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2219-2234
[7]  
ANDERSON CJ, 1995, J NUCL MED, V36, P2315
[8]  
ANDERSON CJ, 1992, J NUCL MED, V33, P1685
[9]   AGE-DEPENDENT VARIATION OF SE-75 BIOKINETICS IN RAT [J].
ARCHIMBAUD, Y ;
GRILLON, G ;
PONCY, JL ;
MASSE, R .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1993, 64 (03) :329-333
[10]   VALIDATION OF [1-C-11]ACETATE AS A TRACER FOR NONINVASIVE ASSESSMENT OF OXIDATIVE-METABOLISM WITH POSITRON EMISSION TOMOGRAPHY IN NORMAL, ISCHEMIC, POSTISCHEMIC, AND HYPEREMIC CANINE MYOCARDIUM [J].
ARMBRECHT, JJ ;
BUXTON, DB ;
SCHELBERT, HR .
CIRCULATION, 1990, 81 (05) :1594-1605